CN EN
news
BioAtla Partners With Bioduro to Advance Two Proprietary Antibody Therapeutics in China
Novmber 4, 2014 – “The Chinese pharmaceutical market is growing at an extremely rapid rate, and is predicted to be the second-largest pharmaceutical market in the world by 2020,” said Jasmine Cui, general manager and c
November 04, 2014
BioDuro Opens State-of-the-Art Discovery Lab in Shanghai
Beijing, September 6, 2013 – BioDuro, A PPD® Company, unveiled its new state-of-the-art laboratory in Shanghai during a grand opening ceremony on 6 Sept. The facility is located in the Waigaoqiao Free Trade Zone in close pro
September 06, 2013
Dow AgroSciences, BioDuro to Collaborate on Crop Protection Discovery Research
INDIANAPOLIS and WILMINGTON, N.C. , February 7, 2012 – Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and BioDuro, announced today a three-ye
February 07, 2012
BioDuro Wins Pfizer 2010 Difference Maker Award
Beijing, January 1st, 2010 – BioDuro, has been named the recipient of the 2010 Difference Maker Award by Pfizer, Inc.’s, External Research Solutions. The award recognized the quality, productivity and value that BioDuro has
January 01, 2010
Total 84 12...91011121314151617
Register Now!
Webinar: New Modality - Peptides Innovations and a Comprehensive Synthetic Peptide Drug Discovery Platform
June 19, 2024 at 10am ET / 07am PT / 04pm CET
View more
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all